Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07149259 · ClinicalTrials.gov registry record · NA
Assessing the Impact of eSight Go At-Home Usage in Individuals With Visual Impairment
A NA study of Low Vision Aids, sponsored by Brooks Rehabilitation.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07149259: Recruiting NA study of Low Vision Aids, sponsored by Brooks Rehabilitation.
NCT07149259 is a NA study of Low Vision Aids that is actively recruiting participants, run by Brooks Rehabilitation. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07149259, a NA study of Low Vision Aids, is actively recruiting participants, sponsored by Brooks Rehabilitation.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This research aims to test the updated version of Gentex's device, eSight Go, an image enhancing wearable device to assist those with vision impairments limiting activities of daily living.
Primary Outcome
Early Treatment Diabetic Retinopathy Study Chart (ETDRS) assessing visual acuity. A lower logMAR value indicates an improved score.
Conditions Studied
Interventions
- DEVICE At Home Use
Study Locations (1)
Florida
- Brooks Rehabilitation - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-06-18 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT07149259 shows while recruiting
NCT07149259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Low Vision Aids appearing as the primary indexed condition, and to 1 intervention - of which At Home Use is the first listed.
NCT07149259 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07149259 about?
NCT07149259 is a clinical study titled "Assessing the Impact of eSight Go At-Home Usage in Individuals With Visual Impairment". This research aims to test the updated version of Gentex's device, eSight Go, an image enhancing wearable device to assist those with vision impairments limiting activities of daily living.
What is the current status of trial NCT07149259?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-06-18. Estimated completion is 2026-06-01.
What conditions does trial NCT07149259 study?
This clinical trial studies the following conditions: Low Vision Aids.
What interventions are being tested in trial NCT07149259?
The interventions under investigation include: At Home Use (DEVICE).
Who is sponsoring clinical trial NCT07149259?
This trial is sponsored by Brooks Rehabilitation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07149259 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Vision Aids
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07149259's enrollment target sits among peer trials
50 1280th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI